Back to search results

Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Renal Pelvis and Ureter Urothelial Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Ankush Sachdeva) · asachdeva@mednet.ucla.edu · 310-794-3421
    Contact: Principal Investigator (Karim Chamie)
Study leads

  • Karim Chamie

    Principal Investigator

    UCLA / Jonsson Comprehensive Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)